INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$4,293
412 sh
Jan 5, 2026Jan 6, 2026
Page 1577 of 1855
← PrevNext →
traded Jan 5, 2026
+1d
SEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$39K
207 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$8,850
46 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
2,520 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
2,520 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

0
SV
Singh VikasEVP & Chief Financial Officer
HCSGHEALTHCARE SERVICES GROUP INC
Option exercise · 10b5-1 plan
M—
3,980 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Option exercise · 10b5-1 plan
M—
2,409 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
412 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Option exercise · 10b5-1 plan
M—
2,409 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,796 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
SV
Singh VikasEVP & Chief Financial Officer
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A—
17.8K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$19K
102 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
204 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,409 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$3,918
21 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

60
RV
Raghunathan VivekSVP, Engineering and Support
SNOWSnowflake Inc.
Open-market sale
SELL$2.60M
11.8K sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

53
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Open-market sale
SELL$1.92M
108.6K sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

43
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Open-market sale
SELL$5.85M
346.1K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

43
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Open-market sale
SELL$3.05M
175.7K sh
Jan 5, 2026Jan 5, 2026
traded Jan 5, 2026
+0dSEC Form 4

Evidence

36
SC
Shrader Glenn CEVP & General Counsel
MCHBMechanics Bancorp
Grant or award
A—
19.5K sh
Sep 2, 2025Jan 5, 2026
traded Sep 2, 2025
+125dSEC Form 4

Evidence

36
PF
Pelayo FernandoEVP & Chief Accounting Officer
MCHBMechanics Bancorp
Grant or award
A—
65.0K sh
Sep 2, 2025Jan 5, 2026
traded Sep 2, 2025
+125dSEC Form 4

Evidence

36
PD
Pierce Christopher DEVP & Chief Operating Officer
MCHBMechanics Bancorp
Grant or award
A—
21.8K sh
Sep 26, 2025Jan 5, 2026
traded Sep 26, 2025
+101dSEC Form 4

Evidence

36
KP
Kallingal Tony PEVP & Chief Banking Officer
MCHBMechanics Bancorp
Grant or award
A—
20.0K sh
Sep 26, 2025Jan 5, 2026
traded Sep 26, 2025
+101dSEC Form 4

Evidence

36
KP
Kallingal Tony PEVP & Chief Banking Officer
MCHBMechanics Bancorp
Grant or award
A—
38.2K sh
Sep 2, 2025Jan 5, 2026
traded Sep 2, 2025
+125dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$6,510
35 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

32
EW
Eager William WPresident, S&P Global Mobility
SPGIS&P Global Inc.
Option exercise
M$1.92M
3,670 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

31
RR
Renninger RobertChief Financial Officer
ATHALeonaBio, Inc.
Open-market sale
SELL$2,043
297 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

30
AS
Armul ScottChief Product and Tech Officer
VRTVertiv Holdings Co
Grant or award
A$2.00M
11.4K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

30
YR
Yassine RamiPresident - Eastern Hemisphere
HALHALLIBURTON CO
Grant or award
A$1.22M
41.2K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

29
BD
Beker DavidEVP, MARKETING
ALSUMISHO AIR LEASE CORP
Tax withholding
F$638K
9,933 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

29
BD
Beker DavidEVP, MARKETING
ALSUMISHO AIR LEASE CORP
Tax withholding
F$430K
6,701 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

29
BD
Beker DavidEVP, MARKETING
ALSUMISHO AIR LEASE CORP
Tax withholding
F$535K
8,330 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

28
RR
Renninger RobertChief Financial Officer
ATHALeonaBio, Inc.
Grant or award
A$2,310
1,000 sh
Nov 18, 2025Jan 5, 2026
traded Nov 18, 2025
+48dSEC Form 4

Evidence

27
TC
Twomey ChristinaChief Communications Officer
SPGIS&P Global Inc.
Option exercise
M—
60 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

27
HA
Harris Mark AndrewVP & Chief Revenue Officer
CCOICOGENT COMMUNICATIONS HOLDINGS, INC.
Grant or award
A—
100.0K sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

27
GG
Ganesan GirishEVP, Chief People Officer
SPGIS&P Global Inc.
Option exercise
M—
74 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

27
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Option exercise
M—
1.02M sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

27
BD
Beker DavidEVP, MARKETING
ALSUMISHO AIR LEASE CORP
Grant or award
A—
19.6K sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence